• (As Principle Investigator):

2017-2019 Developing new inhibitors of LC3/ATG8 and p62/SQSTM1 in cancer, Funding Agency: National Institute of Genetics Engineering and Biotechnology, International Grants.

2015-2018 Targeting autophagy and ER stress in leukemia,

Funding Agency: National Institute for Medical Research Development.

2013-2017 NIGEB Welcome Grants.

2013-2015 Pro-oxidant nanoparticles and regulated cell death, Funding Agency: President Office of Iran.

2012-2013 Targeting GTP-binding protein nucleostemin in leukemia, Funding Agency: National Institute of Genetics Engineering and Biotechnology

19. Co-Principle Investigator):

2019-2021 Evaluating therapeutic potentials of Ire1 arm of the UPR in colorectal cancer,

Funding Agency: National Institute for Medical Research Development